We have previously shown down-regulation of thiamine transporters in human tumors [2], [3], suggesting that tumors may have a nutritional vulnerability that could be exploited clinically, analogous to the down-regulation of asparagine synthase in acute lymphoblastic leukemia which is exploited therapeutically by the bacterial enzyme asparaginase. Here, ASPG is linked to acute lymphoblastic leukemia.